Analytical Method Development and Validation for the Simultaneous Estimation of Azelnidipine and Telmisartan by RP-HPLC in Bulk and Tablet Dosage Forms

Author:

Ahmad Sufiyan1,Sonawane Nikhil1,Tatiya A. U.1

Affiliation:

1. Department of Quality Assurance, Gangamai College of Pharmacy, Nagaon, Dist. Dhule (M.S.), India.

Abstract

An accurate, precise and reproducible RP-HPLC method was developed for the simultaneous quantitative determination of Azelnidipine and Telmisartan in tablet dosage forms. Agilent (S.K) Gradient System UV Detector and C18 column with 250mm x 4.6mm i.d and 5μm particle size Acetonitrile: ph Buffer (80:20v/v) pH 3 was used as the mobile phase for the method. The detection wavelength was 237nm and flow rate was 0.9 ml/min. In the developed method, the retention time of Azelnidipine and Telmisartan were found to be 4.77 min and 11.97min. The developed method was validated according to the ICH guidelines. The linearity, precision, range, robustness was within the limits as specified by the ICH guidelines. Hence the method was found to be simple, accurate, precise, economic and reproducible. The developed method was validated according to the ICH guidelines. In this methods linearity, precision, range, robustness were observed. The method was found to be simple, accurate, precise, economic and reproducible. So the proposed methods can be used for the routine quality control analysis of AZN and TMZ in bulk drug as well as in formulations.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference23 articles.

1. Walker R and Whittlesea C. Clinical Pharmacy and Therapeutics; 5 th Edn; Elsevier, 2007; 295-307.

2. Tamargo J and Ruilope LM., Investigational calcium channel blockers for the treatment of hypertension, Expert Opinion on Investigational Drug, 2016; 1-51.

3. Goodman and Gilman’s The pharmacological basis of therapeutics; 10th Edn; Medical Publishing Division, 2001; 1804.

4. Shewale VU et al., Azelnidipine: A Review on Therapeutic Role in Hypertension. Journal of Drug Delivery and Therapeutics, 2019; 9: 1002-1005. doi.org/10.22270/jddt.v9i3-s.3090.

5. Chen B, Yin Zhuang Zhang, Jian Quan Luo. Wei Zhang. Clinical use of Azelnidipine in the treatment of hypertension in Chinese patients. Therapeutics and Clinical Risk Management, 2015; 11: 309-318. doi: 10.2147/TCRM.S64288.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3